Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,622
Award facts
- Contract value 100% obligated
- $10,622.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,622.20 to AmerisourceBergen Drug Corp for 30-count tablets of Dovato 50-300 mg on December 18, 2025, with completion scheduled for December 19, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Dovato is an antiretroviral medication used in HIV treatment, and this delivery supports the federal military healthcare supply chain managed by the Defense Logistics Agency.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen has demonstrated capability to fulfill federal procurement requirements through open competition across multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q62?
SPE2DR26F9Q62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9Q62 worth?
The government has obligated $10,622 on SPE2DR26F9Q62.
Is contract SPE2DR26F9Q62 an order under another contract?
Yes. SPE2DR26F9Q62 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Q62 competed?
The extent of competition for SPE2DR26F9Q62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award